Overexpression of the human manganese superoxide dismutase (MnSOD) transgene in subclones of murine hematopoietic progenitor cell line 32D cl 3 decreases irradiation-induced apoptosis but does not alter G2/M or G1/S phase cell cycle arrest

Radiation Oncology Investigations

Volumn 7, Issue 6, 1999, Pages 331-342

  Epperly, Michael W ^a   Bray, Jenifer A ^a   Esocobar, Patricia ^a   Bigbee, William L ^a   Watkins, Simon ^a   Greenberger, Joel S ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Apoptosis; Cell cycle regulation; MnSOD

Indexed keywords

CELL DNA; MANGANESE SUPEROXIDE DISMUTASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CLONE; CELL CYCLE; CELL SURVIVAL; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENZYME ACTIVITY; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; TRANSGENE;

ANIMAL; APOPTOSIS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL SURVIVAL; CLONE CELLS; G2 PHASE; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HUMAN; MICE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE;

EID: 0033398125     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:6<331::AID-ROI3>3.0.CO;2-M     Document Type: Article

References (46)

1. Epperly MW, Bray J, Kraeger S, Zwacka R, Engelhardt J, Travis E, Greenberger JS. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther 1998;5:196-208.
2. Epperly MW, Bray JA, Kraeger S, Berry LA, Gooding W, Engelhardt JF, Zwacka R, Travis EL, Greenberger JS. Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Radiat Oncol Biol Phys 1999;43(1):169-181.
3. Greenberger JS, Sakakeeny MA, Humphries KC, Eaves CG, Eckner RJ. Demonstration of permanent factor-dependent multipotential erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 1983;80:2931-2935.
4. FitzGerald TJ, Renault S, Sakakeeny MA, Santucci MA, Pierce JH, Anklesaria P, Kase K, Lovington K, Greenberger JS. Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate. Radiat Res 1990;122:44-53.
5. FitzGerald TJ, Santucci MA, Das IJ, Kase K, Pierce JH, Greenberger JS. The v-abl, c-fms or v-myc oncogene induces gamma radiation resistance of hematopoietic cell line 32D cl 3 at clinical low-dose-rate. Int J Radiat Oncol Biol Phys 1991;21:1203.
6. Santucci MA, Anklesaria P, Anderson SM, Kase K, Sakakeeny MA, Greenberger JS. The v-src oncogene may not be responsible for the increased radioresistance of hematopoietic progenitor cells expressing the v-src. Radiat Res 1992;129:297-303.
7. Anderson SM, Carroll P, Lee FD. Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle. Oncogene 1990;5:317-375.
8. Santucci MA, Anklesaria P, Laneuville P, Das JJ, Sakakeeny MA, FitzGerald TJ, Greenberger JS. Expression of p210 bcr/abl increases hematopoietic progenitor cell radiosensitivity. Int J Radiat Oncol Biol Phys 1993;26: 831-836.
9. Epperly MW, Santucci MA, Reed J, Shields D, Halloran A, Greenberger JS. Expression of the human bcl-2 transgene increases the radiation resistance of a hematopoietic progenitor cell line. Radiat Oncol Invest Clin Basic Res 1994;2:77-84.
10. Epperly MW, Berry LM, Halloran A, Greenberger JS. Increased irradiation resistance in 32D cl 3 hematopoietic progenitor cells overexpressing D-type cyclins. Radiat Res 1995;143:245-254.
11. Quinlan T, Spivack S, Mossman BT. Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 1994;102(Suppl 2):79-87.
12. Tsan MF. Superoxide dismutase and pulmonary oxygen toxicity. Proc Soc Exp Biol Med 1997;214:107-113.
13. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995;64:97-112.
14. Akashi M, Hachiya M, Paquette RL, Osawa Y, Shimizu S, Suzuki G. Irradiation increases manganese superoxide dismutase mRNA levels in human fibrosis. J Biol Chem 1995;270(26):15864-15869.
15. Hardmeier R, Hoeger H, Fang-Kircher S, Khoschsorur A, Lubec G. Transcription and activity of antioxidant enzymes after ionizing irradiation in radiation-resistant and radiation-sensitive mice. Proc Natl Acad Sci USA 1997;94:7572-7576.
16. Hirose K, Longo DL, Oppenheim JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to IL-1, TNF, selected anticancer drugs and ionizing radiation. FASEB J 1993;7:361-368.
17. Li JJ, Oberley LW. Overexpression of manganese-containing superoxide dismutase confers resistance to the cytotoxicity of TNF-α and/or hyperthermia. Cancer Res 1997;57:1991-1998.
18. Lindau-Syepard B, Shaffer JB, Del Vecchio PJ. Overexpression of manganese superoxide dismutase (MnSOD) in pulmonary endothelial cells confers resistance to hyperoxia. J Cell Physiol 1994;161:237-242.
19. Urano M, Kuroda M, Reynolds R, Oberley TD, St. Clair DK. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene radiotherapy. Cancer Res 1995;55(12):2490-2493.
20. Wispe JR, Warner BB, Clark JC, Dey CR, Neman J, Glasser SW, Crapo JD, Chang LY, Whitsett JA. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 1992;267(33):23937-23941.
21. Wong GHW. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim Biophys Acta 1995;1271:205-209.
22. Wong, GHW, Elwell JH, Oberley LW, Goeddel DV. Manganese superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989;58:923-931.
23. Zwacka RM, Dudus L, Epperly MW, Greenberger JS, Engelhardt JF. Redox gene therapy protects against ionizing radiation induced apoptosis. Hum Gene Ther 1998;9(9):1381-1386.
24. Iizuka S, Taniguchi N, Makita A. Enzyme-linked immunoabsorbent assay for human manganese containing superoxide dismutase and its content in lung cancer. J Natl Cancer Inst 1984;72:1043-1049.
25. St. Clair DK, Holland JC. Complementary DNA encoding human colon cancer manganese superoxide dismutase and the expression of its gene in human cells. Cancer Res 1991;51:939-943.
26. Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, Trent JM. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA 1993;90:3113-3117.
27. Li JJ, Oberley LW, St. Clair DK, Ridnour LA, Oberley TD. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 1995;10(10):1989-2000.
28. Zhong W, Oberley LW, Oberley TD, St. Clair DK. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 1997;14(4):481-490.
29. Ihle JN, Keller J, Greenberger JS, Henderson L, Yetter RA, Morse HC. Phenotypic characteristic of cell lines requiring IL-3 for growth. J Immunol 1982;129(4): 1377-1383.
30. Hurwitz DR, Kirchgesser M, Merrill W, Galanopoulos T, McGrath CA, Emami S, Hansen M, Cherington V, Appel JM, Bizinkauska CB. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum Gene Ther 1997;8(2):137-156.
31. Oberley LW, Spitz DR. Nitroblue tetrazolium. In: Greenwald RA, editor. CRC handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press; 1985, p 217-230.
32. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989;179:8-18.
33. Albright N. Computer programs for the analysis of cellular survival data. Radiat Res 1987;112:331-340.
34. Santucci MA, FitzGerald TJ, Harigaya K, Woda B, Sakakeeny MA, Anklesaria P, Kase K, Holland CA, Greenberger JS. Gamma irradiation response of cocultivated bone marrow stromal cell lines of differing intrinsic radiosensitivity. Int. J Radiat Oncol Biol Phys 1990;18:1083-1092.
35. Olive PL. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine. Br J Cancer 1995;71:529-536.
36. Motulsky H. Intuitive biostatistics. New York: Oxford Press. p 221-224.
37. Coligar JE, Kruisbeck AM, Margulies JH. Current protocols in immunology. New York: John Wiley & Sons; 1992. p 5.7.1-5.7.6.
38. Griffiths SD, Clarke AR, Healy LE, Ross G, Ford AM, Hooper ML, Wyllie AH, Greaves M. Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene 1997;14(5):523-531.
39. Levine AJ. P53 the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
40. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome-C from isolated mitochondria. Proc Natl Acad Sci USA 1998;95:4997-5002.
41. Goping JS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K, Korsmeyer SJ, Shore GC. Regulated targeting of Bax to mitochondria. J Cell Biol 1998;143:207-215.
42. Mancini M, Nicholson DW, Roy S, Thomberry NA, Peterson EP, Casciola-Rosen LA, Rosen A. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol 1998;140:1485-1495.
43. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 1996;86: 147-157.
44. Vander Heiden MG, Chandal NS, Williamson EK, Schumacker PT, Thompson CB. bd-xl regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997;91:627-637.
45. Zwacka RM, Zhou W, Zhang Y. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kB activation. Nat Med 1998;4:698-704.
46. Shimizu S, Eguchi Y, Kamiike W, Funahashi Y, Mignon A, Lacronique V, Matsuda H, Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci USA 1998;95: 1455-1459.